骨痹饮治疗强直性脊柱炎的临床与实验研究

目的：观察骨痹饮治疗强直性脊柱炎的疗效及其机理。方法：造反强直性脊柱炎活动期患者７０例，用骨痹饮（治疗组４０例）和消炎痛（对照组３０例）随机分组治疗，并进行了动物实验研究观察。结果：临床控显率治疗组（５７．５％）优于对照组（２３．３％，Ｐ〈０．０１），总有效率两组比较无显著性差异；对缓解关节症状，改善关节功能，防止骨破坏及实验室各项检测指标治疗线均明显优于对照组（Ｐ〈０．０５或Ｐ〈０．０１）。骨痹

Clinical and Experimental Study on Treatment of Ankylosing Spondylitis

Objective: To explore the effect and mechanism of Gubiyin (GBY) in treating ankylosing spondylitis (AS). Methods: The 70 patients of AS were randomly divided into two groups, 40 patients in the GBY group were treated with GBY and 30 patients treated with indomethacin for control. Animal experiments were also conducted. Results: Clinical observation showed that the markedly effective rate of the GBY group (57.5%) was higher than that of the control group (23.3%, P<0 01), but the total effective rate of the two groups were similar. The effects of GBY in relieving symptoms of joints, improving function of joints, preventing degeneration of bone and improving laboratory parameters were better than those of indomethacin. In animal experiments, GBY showed its inhibition on granuloma formation, adjuvant arthritis in mice, and IL 1 production of abdominal macrophage and IL 2 production of spleen cell in rats. Conclusion: GBY has effects of anti inflammation, analgesic, immunoregulation, inflammation mediator inhibition and hemorrheology improvement.